Sheaff Brock Investment Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,700	Closed	-$236K	–	515
2020 Q3	$236K	Buy	+5,700	New	+$262K	0.02%	353
2018 Q3	–	Sell	-3,150	Closed	-$264K	–	565
2018 Q2	$264K	Buy	+3,150	New	+$231K	0.03%	394
2017 Q3	–	Sell	-3,150	Closed	-$381K	–	631
2017 Q2	$381K	Hold	3,150	–	–	0.05%	335
2017 Q1	$356K	Hold	3,150	–	–	0.05%	346
2016 Q4	$342K	Sell	3,150 -1,200	-28%	-$143K	0.04%	362
2016 Q3	$716K	Hold	4,350	–	–	0.1%	210
2016 Q2	$621K	Buy	4,350 +50	+1%	+$7.29K	0.08%	245
2016 Q1	$552K	Hold	4,300	–	–	0.07%	268
2015 Q4	$642K	Buy	+4,300	New	+$728K	0.07%	271

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Sheaff Brock Investment Advisors's ICPT Position: Q4 2020 in Review

Sheaff Brock Investment Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2020, closing a stake of 5,700 shares — an estimated $236K sold.

Sheaff Brock Investment Advisors first reported a position in ICPT in Q4 2015 and held it in 9 quarters. The position peaked at $716K in Q3 2016. 175 funds tracked by Wall St. Rank hold ICPT as of Q4 2020.

Sheaff Brock Investment Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Sheaff Brock Investment Advisors sold 5,700 Intercept Pharmaceuticals, Inc. shares in Q4 2020, an estimated $236K.
Sheaff Brock Investment Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2015 and held it in 9 quarters.
Sheaff Brock Investment Advisors's Intercept Pharmaceuticals, Inc. position peaked at $716K in Q3 2016.
175 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2020.

Based on Sheaff Brock Investment Advisors's 13F filing for Q4 2020, filed 1 Feb 2021.